Eyeing margin growth, acquisitions on cards: Nucleus
January 24, 2017
Speaking to CNBC-TV18 Vishnu R Dusad - MD & CEO of the company said the company has right mix of innovative products to monetise the cash crunch scenario. He however added it will take some time for the benefits to trickle down to growth in revenue.